Treatment of Parkinson's disease in early and late phases. Use of pharmacological agents with special reference to deprenyl (selegiline).

v1

Type:Journal Article

0 views

[![NobleID](https://www.nobleid.org/api/badge/70797CCC.svg?ark=w1%2F20260515%2F70797CCC)](https://nobleid.org/work/w1/20260515/70797CCC)

ARK Inflections

Bibliometric Analysis

Impact metrics, research fronts, co-authorship networks →

Authors & Claims

Paper Authors